stocks logo

BCRX Valuation

BioCryst Pharmaceuticals Inc
$
8.615
+0.065(0.760%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

BCRX Relative Valuation

BCRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BCRX is overvalued; if below, it's undervalued.

Historical Valuation

BioCryst Pharmaceuticals Inc (BCRX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.92 is considered Undervalued compared with the five-year average of -34.44. The fair price of BioCryst Pharmaceuticals Inc (BCRX) is between 15.26 to 45.62 according to relative valuation methord. Compared to the current price of 8.54 USD , BioCryst Pharmaceuticals Inc is Undervalued By 44.01%.
Relative Value
Fair Zone
15.26-45.62
Current Price:8.54
44.01%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-3.98
P/B
Median3y
-4.65
Median5y
-11.58
-1.49
FCF Yield
Median3y
-6.89
Median5y
-7.43

Competitors Valuation Multiple

The average P/S ratio for BCRX's competitors is 17.15, providing a benchmark for relative valuation. BioCryst Pharmaceuticals Inc Corp (BCRX) exhibits a P/S ratio of 2.92, which is -82.96% above the industry average. Given its robust revenue growth of 56.89%, this premium appears sustainable.

FAQ

arrow icon

Is BioCryst Pharmaceuticals Inc (BCRX) currently overvalued or undervalued?

BioCryst Pharmaceuticals Inc (BCRX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.92 is considered Undervalued compared with the five-year average of -34.44. The fair price of BioCryst Pharmaceuticals Inc (BCRX) is between 15.26 to 45.62 according to relative valuation methord. Compared to the current price of 8.54 USD , BioCryst Pharmaceuticals Inc is Undervalued By 44.01% .
arrow icon

What is BioCryst Pharmaceuticals Inc (BCRX) fair value?

arrow icon

How does BCRX's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for BioCryst Pharmaceuticals Inc (BCRX) as of Jul 25 2025?

arrow icon

What is the current FCF Yield for BioCryst Pharmaceuticals Inc (BCRX) as of Jul 25 2025?

arrow icon

What is the current Forward P/E ratio for BioCryst Pharmaceuticals Inc (BCRX) as of Jul 25 2025?

arrow icon

What is the current Forward P/S ratio for BioCryst Pharmaceuticals Inc (BCRX) as of Jul 25 2025?